Stay updated with breaking news from Achl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […]
Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is set to announce its earnings results on Tuesday, April 2nd. Achilles Therapeutics Stock Performance Shares of NASDAQ ACHL opened at $1.25 on Monday. The business has a fifty day simple moving average of $1.14 and a 200 day simple moving average of $0.96. The company has a […]
Bank of America reaffirmed their underperform rating on shares of Achilles Therapeutics (NASDAQ:ACHL – Free Report) in a report released on Thursday morning, Benzinga reports. Achilles Therapeutics Stock Up 1.2 % Shares of Achilles Therapeutics stock opened at $0.87 on Thursday. The firm’s 50 day moving average price is $0.86 and its 200-day moving average […]
Achilles Therapeutics (NASDAQ:ACHL – Get Free Report)‘s stock had its “underperform” rating reaffirmed by investment analysts at Bank of America in a research note issued to investors on Thursday, Benzinga reports. Achilles Therapeutics Trading Down 7.6 % Shares of NASDAQ:ACHL traded down $0.07 during midday trading on Thursday, hitting $0.89. 209,674 shares of the stock […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report)’s stock price shot up 1.8% during trading on Monday . The company traded as high as $0.85 and last traded at $0.84. 151,863 shares changed hands during trading, a decline of 10% from the average session volume of 167,858 shares. The stock had previously closed at $0.82. […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) shares shot up 1.8% on Monday . The company traded as high as $0.85 and last traded at $0.84. 151,863 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 167,858 shares. The stock had previously closed at $0.82. Wall Street […]
Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) is scheduled to be issuing its quarterly earnings data on Monday, November 6th. Achilles Therapeutics (NASDAQ:ACHL – Get Free Report) last posted its quarterly earnings data on Friday, August 4th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.02). […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 14,800 shares, a growth of 114.5% from the April 30th total of 6,900 shares. Approximately 0.0% of the company’s shares are sold short. Based […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 13,000 shares, a growth of 106.3% from the March 15th total of 6,300 shares. Based on an average daily volume of 258,600 shares, the short-interest ratio is […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 6,300 shares, a decrease of 33.7% from the February 28th total of 9,500 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average […]